Scientist Reveals a Newly Discovered Cause of Insulin Resistance (Not Carb Related) | Dr. Stephanie Venn-Watson

Dr. Stephanie Venn-Watson is the CEO of Seraphina Therapeutics which has been recognized for its extensive research and education on pentadecanoic acid (C15:0). Show sponsor: BiOptimizers - 10% off Magnesium Breakthrough by using the code "ultimatehealth" at checkout Show notes: https://ultimatehealthpodcast.com/627